To review the recent evidence demonstrating how the renal dopaminergic and angiotensin systems control renal electrolyte balance through various receptormediated pathways with counterregulatory interactions.
Introduction
The counterregulation of the renal dopaminergic and rennin-angiotensin system (RAS) will be examined in this review from the perspective of receptor-receptor interactions. The first part of the review will highlight the recent studies examining how the dopaminergic system affects the regulation of the angiotensin type 1 R (AT 1 R). The next part of the review will summarize recent evidence that the dopaminergic system upregulates and activates the angiotensin type 2 receptor (AT 2 R). The third section will review the evidence that the dopaminergic system in part counterregulates the RAS by decreasing the production of reactive oxygen species (ROS).
Dopamine inhibition of the angiotensin type 1 receptor
The kidney, which regulates sodium and water balance, is a central organ in the regulation of electrolyte levels and blood volume in the body. Guyton et al.
[1] described the relationship between blood pressure (BP) and sodium excretion as the pressure-natriuresis curve. Increases in BP cause increased natriuresis in order to return the BP to normal. However, impairments in the pressurenatriuresis relationship cause a rightward shift in the curve necessitating increased BP in order to restore blood volume to normal. The biochemical mechanisms governing the pressure-natriuresis relationship are just beginning to be understood with the RAS and dopaminergic systems acting as counterregulatory pathways involved in this process. There are two principal pathways that are responsible for the regulation of BP, namely the natriuretic intrarenal dopamine system and the antinatriuretic RAS [2] . In order to conserve sodium during times of low sodium intake, the RAS is upregulated in order to produce angiotensin II (Ang II). Stimulation of the principal membrane-bound cell surface receptor for Ang II, the AT 1 R, leads to sodium reabsorption. In order to eliminate sodium during times of high sodium intake, the local renal production of dopamine is increased leading to inhibition of sodium reabsorption. Hypertension, or an inappropriately high BP, can result when the kidney is unable to eliminate sodium and thus retains excess water leading to increased blood volume.
The renal RAS is a hormone cascade with the peptide hormone Ang II acting as its major product. Ang II exerts its effects primarily through the stimulation of AT 1 R leading to sodium reabsorption by the proximal tubule of the kidney. The first study clearly showing the inhibitory activity of dopamine on the Ang II-dependent increase in renal brush border sodium uptake in vitro was shown by Sheikh-Hamad et al.
[3], who measured radioactive 22 Na uptake in isolated renal proximal tubule brush border vesicles. Both the D 1 -like and D 2 -like receptor activities were necessary for full inactivation of an Ang II-dependent increase in sodium uptake. Cheng et al.
[4] then determined that the dopaminergic effect was accompanied by a downregulation of the AT 1 R both in vivo as well as in cultured cells, suggesting that the effect was not dependent on an intact kidney. Zeng et al. [5] further demonstrated that Ang II stimulation caused a decrease in the D 5 R in proximal tubule cells from normotensive Wistar-Kyoto (WKY) rats and spontaneously hypertensive rats (SHRs). Ang II stimulation caused a decrease in expression of AT 1 R in WKY cells, yet caused an increase in AT 1 R expression in SHR. The AT 1 R and D 5 R were also found to colocalize in cells, with the SHR rats having a lower basal expression of D 5 R. The AT 1 R and D 5 R are thought to be counterregulatory as AT 1 R knockout animals have increased expression of D 5 R, and D 5 R knockout mice have an increased expression of AT 1 R.
Gildea et al.
[6 ] recently showed which D 1 -like receptor was responsible for the downregulation of the AT 1 R in human renal proximal tubule cells. Using antisense oligos, specific to the D 1 R or the D 5 R in primary cultured human renal proximal tubule cells, they presented evidence that it was the D 5 R that was mediating the D 1 -like effect on AT 1 R. These studies utilized renal proximal tubular cells in which the D 1 R was uncoupled from adenylyl cyclase stimulation. The D 5 R downregulation of the AT 1 R was intact in adenylyl cyclase uncoupled cells, further suggesting that this was a D 1 R and possibly a cAMP independent effect. This study also showed for the first time that c-src is activated by stimulation of D 1like receptors and that the downregulation of the AT 1 R is mediated by a c-src and a proteasome-dependent protein degradation mechanism. Similarly, Li et al.
[7 ] showed the D 5 R that caused the ubiquitination and proteasomal degradation of the AT 1 R, using both in-vitro and in-vivo techniques. He suggested that the elevated BP (relative to controls) in D 5 R knockout mice was due to the overexpression of the AT 1 R. Another important finding was that the elevated BP in the D 5 R knockout mice could be returned to baseline using an AT 1 R inhibitor, losartan. They further showed that the D 5 R and AT 1 R physically interact at the cell surface by coimmunoprecipitation and that the AT 1 R, which is ubiquitinated and degraded by the proteasome, is the N-glycosylated form of the AT 1 R. How c-src is activated by the D 5 R and what role it plays in the ubiquitination and degradation of the AT 1 R is yet to be determined. The dopamine D 4 receptor (D 4 R) knockout mice also have an overexpression of renal AT 1 R and a differential response to an AT 1 R inhibitor, losartan, with the D 4 knockout mice displaying an extended decrease in BP reduction with bolus infusion of the AT 1 R antagonist [8] . There may be direct antagonism between the dopamine and the RAS as either the D 1 R, D 3 R, or D 5 R can physically interact with the AT 1 R [7 , 9, 10, 11 ] .
Dopamine-dependent upregulation of the angiotensin type 2 receptor
The stimulation of the AT 2 R antagonizes many of the effects of the AT 1 R [12] . The AT 1 R and the AT 2 R can physically interact, producing the antagonism between the two signaling pathways [13] . The fact that the stimulation of the AT 1 R increases Na/K ATPase activity has been demonstrated numerous times, whereas the AT 2 R was shown to inhibit Na/K ATPase in isolated rabbit renal proximal tubule cells [14, 15] . AT 2 R stimulation was also shown to induce natriuresis in obese Zucker and steptozocin-induced diabetic rats via a nitric oxide, soluble guanylyl cyclase, and cGMP mechanism [16, 17] . In human renal proximal tubule cells, it was also shown that this same downstream pathway leads to cGMP export from the cell and inhibited sodium absorption [18] . Gildea et al. [19] found that, in immortalized human renal proximal tubule cells, D 1 -like stimulation caused the AT 2 R to translocate to the cell surface and opposed the ability of AT 1 R to decrease the expression of caveolin 1, and this only occurred in cells isolated from normotensive patients. Salomone et al. [20 ] showed that D 1 -like stimulation caused AT 2 R to translocate to the brush border of the rat renal proximal tubule in vivo. This study also showed that pharmacologically blocking the AT 2 R blocked the dopamine D 1 -like-dependent natriuresis. Interstitial infusion of fenoldopam, a D 1 -like specific agonist, caused a proximal tubule-dependent natriuresis in salt-loaded adult rats, and coinfusion of an AT 2 R specific blocking compound, PD-123319 [21] , blocked the effect, suggesting that the AT 2 R is necessary for D 1 -like effects on natriuresis.
The production of Ang II is downregulated in high salt conditions and intrarenal dopamine production is increased [2, 22] . The elimination of the Ang II peptide is mediated by a proteolytic cascade with the conversion of Ang II to Ang III by aminopeptidase A (APA) and the conversion of Ang III to Ang IV by aminopeptidase N (APN), both of which are highly expressed in the brush border of the renal proximal tubule [12] . Natriuresis in normal or low sodium rats was induced by renal interstitial infusion of an AT 1 R inhibitor, losartan, and the natriuresis is fully blocked by the AT 2 R inhibitor PD-123319 [21] . Ang III appears to be the preferred substrate for AT 2 R-dependent natriuresis because the Ang IIIinduced natriuresis is blocked by the AT 2 R inhibitor PD-123319, and is enhanced by blocking the conversion of Ang III to Ang IV by an APN inhibitor [23] . In addition, natriuresis, caused by infusion of renal interstitial Ang II, is blocked if you inhibit the conversion of Ang II to Ang III with an APA inhibitor [24 ] . Perhaps the D 1 -like receptor or some other effect of increased sodium load may increase the conversion of Ang II to Ang III mediated by APA, or may decrease the activity of APN, which would produce an increase in the level of Ang III. A recent study showed that increasing sodium intake in rats caused an upregulation of total kidney expression of AT 2 R [25] . In cell fractionation experiments, AT 2 R and APN shifted to higher density cell fractions interpreted as being inhibited by internalization. The underlying mechanisms behind how dopaminergic stimulation coupled with AT 1 R inhibition and AT 2 R stimulation results in natriuresis remain to be determined.
The dopaminergic system as an antioxidant
Excess Ang II production can lead to renal pathology mediated through the AT 1 R, causing excess growth, inflammation, and fibrosis resulting in chronic hypoxia [26] and increased generation of ROS [27] . Dopamine stimulates antioxidant activity [28 ] and can counterregulate Ang II signaling. Both the dopamine D 2 receptor (D 2 R) and the D 5 R knockout mice have increased ROS production [29, 30] . Interestingly, stimulation of D 5 Rtransfected human embryonic kidney cells decreased ROS generation and was found to be independent of cAMP and protein kinase A (PKA) [29] . In the case of D 5 R knockout mice, there is an overexpression of the AT 1 R [7 ]. Even though losartan was shown to bring the elevated BP in D 5 R knockout mice back to normal and apocynin was also shown to return the BP back to baseline, it has not been shown that adding losartan blocks ROS production in these mice. In D 2 R knockout mice, there is no report of an overexpression of AT 1 R, but it was documented that there was an increase in aldosterone secretion, a known downstream target of Ang II [30] . Consistent with the increase in aldosterone being AT 1 R mediated, increased sodium intake reduced the increase in aldosterone secretion. The addition of spironolactone, an aldosterone antagonist, normalized BP, but did not reduce urinary 8-isoprostane secretion, a measure of renal ROS generation. The dopamine D 3 receptor (D 3 R) knockout mice are also hypertensive, and have an overexpression of the AT 1 R [10] . Interestingly, addition of the dopamine D 3 R-specific agonist, PD128907, decreased expression of AT 1 R in renal proximal tubule cells from WKY rats, but increased expression of AT 1 R in SHRs. The addition of PD128907 also increased D 3 R expression in proximal tubule cells isolated from WKY rats, but not in proximal tubule cells isolated from SHRs, implying not just lack of signaling but also differential signaling of the D 3 R in SHR. The D 3 R and AT 1 R were also found for the first time to colocalize and coimmunoprecipitate from rat renal proximal tubule cells.
Some aspects of the dopaminergic system are not associated with an increase in ROS. G-protein-coupled receptor kinase 4 (GRK4) is a kinase shown to phosphorylate and inactivate the D 1 R [2]. Overexpression of a genetic variant of GRK4 negative (A142V) in mice was shown not to increase ROS [31 ] . The polymorphic version of the construct causes hypertension, presumably the result of hyperphosphorylation and inactivation of the D 1 R, whereas the wild type version of the construct did not [32] . The inactivation of the D 1 R, at least in this instance, is not linked to the increased generation of ROS. Although direct evidence that the D 1 R specifically controls the antioxidant status of renal cells does not yet exist, it is known that an increase in ROS may inhibit D 1 R [33 ,34 ] . Addition of high salt diet alone did not cause a significant increase in BP in Sprague-Dawley rats, whereas the addition of an oxidant-induced salt sensitivity did (a sodium chloride-mediated increase in blood pressure). The salt-sensitive rats were further shown to have a defect in the D 1 -like receptor-dependent increase in fractional sodium excretion, cAMP production, and Na/K ATPase activity, but showed no defect in dopamine production as measured by dopamine secreted into the urine.
In the obese Zucker rat model of ROS-dependent hypertension, it was found that the D 1 R was hyperphosphorylated by GRK 2 and was unable to inhibit Na/K ATPase [35] . It was further shown that this defect is due to an inability to activate phospholipase C (PLC). In this particular model of hypertension, the D 1 -like receptordependent inhibition of Na/K ATPase is insensitive to inhibition of PKA, but is sensitive to protein kinase C inhibitors. Interestingly, they showed that the defect in D 1 R coupling to adenylyl cyclase in obese rats is reversed by dephosphorylating the D 1 R in isolated membranes, yet does not restore PLC activation. There is an increase in the incidence of hypertension as well as an increase in the generation of ROS and inflammation with age. In a recent study, it was shown that age-related hypertension in rats might be reversed through the use of exercise, which reduces several measures of ROS and inflammation in the kidneys from old rats, and at the same time increasing the abundance of D 1 R [36] . A study by Banday and Lokhandwala [37 ] showed that increased oxidative activity (stimulated by L-buthionine sulfoximine) caused an increased AT 1 R abundance in the renal proximal tubule and subsequently hypertension. The use of tempol (a novel cell-permeable superoxide dismutase mimetic) reversed the oxidative stress-induced increase in BP. They further showed a heightened sensitivity to Ang II-dependent increases in inositol triphosphate accumulation, PLC activation, mitogen-activated protein kinase activation, Na/K ATPase activity, and NHE 3 activity.
Conclusion
The natriuretic renal dopaminergic system collectively opposes the antinatriuretic activity of the RAS by downregulating the AT 1 R, upregulating the AT 2 R and inhibiting ROS generation. Each of the individual dopamine receptors has been shown to oppose the activity of the AT 1 R, with the D 1 R, D 3 R, and D 5 R physically interacting with the AT 1 R. The cell signaling pathways used by the individual members of the dopamine receptor family are complex and interconnected, yet work together to maintain normal BP at least in part by inhibiting RAS activity and ROS production.
